中文

新宙邦 Revenue Breakdown

Period 2026-06-30 ・ Reported 2026-08-21

新宙邦 reported revenue of ¥7.46B for the period ended 2026-06-30, +75.7% year on year. Net income was ¥1.00B, a 13.4% net margin on a 23.9% gross margin. The largest revenue line is 电池化学品 at 77% of the total. Free cash flow for the period was ¥0.66B.

ItemAmountY/Y
Revenue¥7.46B+75.7%
Gross profit¥1.78B
Operating income¥1.16B
Net income¥1.00B+101.8%
Gross margin23.9%Net margin 13.4%
Revenue Q/Q+22.0%

Revenue Segments

SegmentRevenueShare
电池化学品¥5.75B77.1%
电子信息化学品¥0.96B12.8%
有机氟化学品¥0.71B9.5%
其他¥0.05B0.6%

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥5.68B76.1%
R&D¥0.29B3.9%
SG&A¥0.35B4.7%
Tax & other¥0.16B2.2%

Balance sheet & cash flow

ItemAmount
Total assets¥23.76B
Total liabilities¥11.92B
Shareholders' equity¥11.84B
Equity / assets49.8%
Operating cash flow¥0.99B
Capital expenditure¥0.33B
Free cash flow¥0.66B
Cash conversion (OCF / net income)113%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

上海凯宝九洲集团回天新材朗科科技星辉娱乐*ST赛为华力创通台基股份天源迪科合康新能福瑞医科世纪鼎利

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies